Swiss Market Closes Modestly Higher

RTTNews | Pred 587 dňami
Swiss Market Closes Modestly Higher

(RTTNews) - The Switzerland stock market ended modestly higher on Tuesday after holding in positive territory right through the day's session.

Bargain hunting at several counter contributed to market's rebound.

The benchmark SMI, which rose to 10,201.23 in the first hour, ended the day with a gain of 53.81 points or 0.53% at 10,126.43.

Roche Holding rallied 2.2%. Logitech gained 2.05%, while Lonza Group, Zurich Insurance Group and ABB advanced 1 to 1.1%.

Novartis, Sika, Sonova and Swisscom posted modest gains.

Credit Suisse and Swiss Re both shed more than 2%. Swiss Life Holding ended lower by about 1.05%. Geberit and Alcon also ended weak.

Among the stocks in the Swiss Mid Price Index, Zur Rose surged 5.57%. AMS gained a little over 5%, and Roche Holding climbed 3.7%.

Galenica Sante, Kuehne & Nagel, Bachem Holding, Schindler Ps and Lindt & Spruengli gained 1.5 to 2.3%.

SGS, Swiss Prime Site, Clariant and PSP Swiss Property declined 2.4 to 2.9%.

read more
Jobs Data Aided Dollar's Tumble Last Week

Jobs Data Aided Dollar's Tumble Last Week

The week ended May 3 witnessed heavy losses for the Dollar as a weaker-than-expected job market update renewed hopes of a rate cut by the U.S. Federal Reserve.
RTTNews | Pred 4 h 41 min
Medical Properties Stock Hit As Steward Health Files For Bankruptcy

Medical Properties Stock Hit As Steward Health Files For Bankruptcy

Medical Properties Trust, Inc.'s shares were losing around 10 percent in the initial trading on the NYSE after its tenant Steward Health Care System, the largest physician-led hospital operator in the United States, announced its filing for bankruptcy protection.
RTTNews | Pred 4 h 42 min
SEC Staff To Recommend The SEC To File Enforcement Action Against Robinhood Crypto

SEC Staff To Recommend The SEC To File Enforcement Action Against Robinhood Crypto

Robinhood Markets, Inc. (HOOD) revealed on Monday in an Form 8-K filing with the U.S. Securities and Exchange Commission that Robinhood Crypto LLC or RHC, received a "Wells Notice" from the Staff of the SEC stating that the Staff has advised RHC that it made a "preliminary determination" to recommend that the SEC file an enforcement action against RHC alleging violations of Sections 15(a) and 17A of the Securities Exchange Act of 1934, as amended.
RTTNews | Pred 4 h 50 min
Warren Buffett's Berkshire Hathaway Cuts Stake In Apple

Warren Buffett's Berkshire Hathaway Cuts Stake In Apple

Warren Buffett's Berkshire Hathaway has trimmed a portion of its significant stake in tech giant Apple Inc., reportedly citing tax reasons. As per its first-quarter earnings report released over the weekend, Hathaway's Apple stock was worth $135.4 billion as of March 31, 2024. This is lower than the $174.3 billion worth Apple stock as of December 31, 2023.
RTTNews | Pred 5 h 1 min
Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Financial services company Cohen & Co. Inc. (COHN) reported Monday net income attributable to Company for the first quarter of $2.02 million or $1.28 per share, compared to a net loss of $2.64 million or $1.77 per share in the prior-year quarter.
RTTNews | Pred 5 h 23 min
Eurozone Private Sector Growth Accelerates In April

Eurozone Private Sector Growth Accelerates In April

The euro area private sector growth accelerated to an 11-month high in April driven by the service sector, final survey results from S&P Global showed on Monday. The HCOB composite output index rose to 51.7 in April from 50.3 in the previous month. The flash estimate was 51.4.
RTTNews | Pred 5 h 33 min
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews | Pred 5 h 54 min